Difficulty: Medium
Average Score: 95%
Practice
A woman taking haloperidol develops a spectrum of adverse effects that include the amenorrhea-galactorrhea syndrome and extrapyramidal dysfunction. Her psychiatrist prescribes a newer antipsychotic drug that improves both positive and negative symptoms of schizophrenia with fewer dopamine receptor blockade side effects. Since weekly blood tests are not deemed necessary, the drug prescribed by the psychiatrist is probably
Correct answer
D
Rationale
The correct answer is option D) Olanzapine. Olanzapine is a second-generation antipsychotic that is known for its efficacy in treating both positive and negative symptoms of schizophrenia while causing fewer extrapyramidal side effects compared to first-generation antipsychotics like haloperidol. Olanzapine works by blocking multiple neurotransmitter receptors, including dopamine, serotonin, and others, leading to a more favorable side effect profile.
Option A) Bupropion is not an antipsychotic drug, but rather an atypical antidepressant that works primarily on norepinephrine and dopamine reuptake inhibition. It is not indicated for schizophrenia.
Option B) Clozapine is an effective antipsychotic, especially for treatment-resistant schizophrenia, but it is associated with a risk of agranulocytosis, requiring regular blood monitoring. The question specifies that weekly blood tests are not necessary, making Clozapine less likely.
Option C) Nefazodone is an antidepressant that primarily affects serotonin receptors and is not commonly used in the treatment of schizophrenia.
In an educational context, understanding the differences between various antipsychotic medications is crucial for healthcare professionals to make informed decisions when prescribing medications for patients with schizophrenia. Knowing the side effect profiles, mechanisms of action, and monitoring requirements of different drugs can help optimize treatment outcomes and patient safety.
Option A) Bupropion is not an antipsychotic drug, but rather an atypical antidepressant that works primarily on norepinephrine and dopamine reuptake inhibition. It is not indicated for schizophrenia.
Option B) Clozapine is an effective antipsychotic, especially for treatment-resistant schizophrenia, but it is associated with a risk of agranulocytosis, requiring regular blood monitoring. The question specifies that weekly blood tests are not necessary, making Clozapine less likely.
Option C) Nefazodone is an antidepressant that primarily affects serotonin receptors and is not commonly used in the treatment of schizophrenia.
In an educational context, understanding the differences between various antipsychotic medications is crucial for healthcare professionals to make informed decisions when prescribing medications for patients with schizophrenia. Knowing the side effect profiles, mechanisms of action, and monitoring requirements of different drugs can help optimize treatment outcomes and patient safety.